| Lola I Toney, COUNSELOR | |
|
6171 Childers Rd Ste 101, Barboursville, WV 25504-1227 | |
| (304) 733-5380 | |
| (304) 733-5796 |
| Full Name | Lola I Toney |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 6171 Childers Rd Ste 101, Barboursville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407413446 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lola I Toney, COUNSELOR 6171 Childers Rd Ste 101, Barboursville, WV 25504-1227 Ph: (304) 733-5380 | Lola I Toney, COUNSELOR 6171 Childers Rd Ste 101, Barboursville, WV 25504-1227 Ph: (304) 733-5380 |
News Archive
The study by a team at Shaare Zedek Medical Centre in Jerusalem, is the first to examine what couples actually did when they learned their unborn child had a condition called Gaucher disease, an inherited condition which can be effectively treated.
DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
Takeda Pharmaceuticals Company Limited will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) cardiovascular (CV) safety outcomes trial in a poster session at the American College of Cardiology's 63rd Annual Scientific Session in Washington, DC.
Targacept, Inc. announced today the pricing of an underwritten public offering of 3,658,537 shares of its common stock at a price to the public of $20.50 per share.
› Verified 3 days ago
Sharla Meade, LPC Counselor Medicare: Medicare Enrolled Practice Location: 3450 Us Route 60 E, Barboursville, WV 25504 Phone: 304-955-6300 Fax: 304-733-5903 | |
Tyler R Burns, MA, LPC, AADC, NCC Counselor Medicare: Medicare Enrolled Practice Location: 6171 Childers Rd, Barboursville, WV 25504 Phone: 304-733-5380 Fax: 304-733-5796 | |
Joshua Parker, LPN Counselor Medicare: Not Enrolled in Medicare Practice Location: 3014 Champion Dr, Barboursville, WV 25504 Phone: 740-479-0067 Fax: 304-900-3629 | |
Jean Culbertson Sutton, M.DIV. Counselor Medicare: Not Enrolled in Medicare Practice Location: 701 Main St, Barboursville, WV 25504 Phone: 304-654-4213 | |
Mrs. Bridget Nicole Stewart, MA, AADC, MAC, SAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 642 Brady St, Barboursville, WV 25504 Phone: 681-886-1036 | |
Kathryn Black, M.ED., NCC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 642 Brady St, Barboursville, WV 25504 Phone: 304-733-1833 |